Straits Times Index
3,175.48 -12.18 (-0.38%) Nikkei
37,068.35 -1,011.35 (-2.66%) Hang Seng
16,242.18 -143.69 (-0.88%) FTSE 100
7,877.05 0.00 (0.00%) Bitcoin USD
64,862.30 +3,706.83 (+6.06%) CMC Crypto 200
1,321.01 +8.38 (+0.64%)
Regen BioPharma, Inc. (RGBP)
- GlobeNewswire
Presenting on the Emerging Growth Conference 69 Day 2 on April 4 Register Now
MIAMI, April 03, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 69th Emerging Growth Conference on April 3 & 4, 2024. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting compani
- PR Newswire
Regen BioPharma, Inc. to Discuss Plans to Move Forward with HemaXellerate into Clinical Phase 1 at the Emerging Growth Conference on April 4, 2024
Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs will be presenting at the Emerging Growth Conference on April 4, 2024 (https://emerginggrowth.com/conference/).
- GlobeNewswire
Presenting on the Emerging Growth Conference 68 Day 2 on March 7 Register Now
MIAMI, March 06, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 68th Emerging Growth Conference on March 6 & 7, 2024. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting compani
